- Home
- VRPX vs NAOV Comparison
VRPX vs NAOV Comparison
Compare VRPX & NAOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRPX
- NAOV
- Stock Information
- Founded
- VRPX 2016
- NAOV 2003
- Country
- VRPX United States
- NAOV United States
- Employees
- VRPX N/A
- NAOV N/A
- Industry
- VRPX Medicinal Chemicals and Botanical Products
- NAOV Industrial Specialties
- Sector
- VRPX Health Care
- NAOV Health Care
- Exchange
- VRPX Nasdaq
- NAOV Nasdaq
- Market Cap
- VRPX 3.6M
- NAOV 3.1M
- IPO Year
- VRPX 2021
- NAOV N/A
- Fundamental
- Price
- VRPX $0.49
- NAOV $2.39
- Analyst Decision
- VRPX Hold
- NAOV
- Analyst Count
- VRPX 1
- NAOV 0
- Target Price
- VRPX N/A
- NAOV N/A
- AVG Volume (30 Days)
- VRPX 444.2K
- NAOV 2.3M
- Earning Date
- VRPX 05-12-2025
- NAOV 05-14-2025
- Dividend Yield
- VRPX N/A
- NAOV N/A
- EPS Growth
- VRPX N/A
- NAOV N/A
- EPS
- VRPX N/A
- NAOV N/A
- Revenue
- VRPX N/A
- NAOV $2,558,000.00
- Revenue This Year
- VRPX N/A
- NAOV N/A
- Revenue Next Year
- VRPX N/A
- NAOV N/A
- P/E Ratio
- VRPX N/A
- NAOV N/A
- Revenue Growth
- VRPX N/A
- NAOV 227.79
- 52 Week Low
- VRPX $1.08
- NAOV $1.92
- 52 Week High
- VRPX $105.98
- NAOV $13.97
- Technical
- Relative Strength Index (RSI)
- VRPX 15.43
- NAOV 36.00
- Support Level
- VRPX $1.08
- NAOV $2.90
- Resistance Level
- VRPX $1.78
- NAOV $3.30
- Average True Range (ATR)
- VRPX 0.39
- NAOV 0.63
- MACD
- VRPX -0.02
- NAOV -0.08
- Stochastic Oscillator
- VRPX 1.63
- NAOV 0.36
About VRPX Virpax Pharmaceuticals Inc.
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.
About NAOV NanoVibronix Inc.
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.